Shire PLC (SHPGY) financial statements (2021 and earlier)

Company profile

Business Address BLOCK 2, MIESIAN PLAZA
DUBLIN 2, D02 HW68
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4725291362,9822,2391,482
Cash and cash equivalents4725291362,9822,2391,482
Restricted cash and investments39268655  
Receivables3,0702,6571,2191,049961824
Inventory, net of allowances, customer advances and progress billings3,2923,562635545455437
Inventory3,2923,562635545455437
Prepaid expense243184363729
Prepaid expense and other current assets222
Other current assets313345704942
Other undisclosed current assets18023874466561247
Total current assets:7,6087,5402,2565,1834,2883,212
Noncurrent Assets
Property, plant and equipment6,6356,470828838892956
Long-term investments and receivables24119251443239
Long-term investments24119251443239
Intangible assets, net (including goodwill)52,87852,58613,3217,4092,9373,033
Goodwill19,83217,8884,1482,475625645
Intangible assets, net (excluding goodwill)33,04634,6989,1734,9342,3132,388
Other noncurrent assets205152334633
Prepaid expense and other noncurrent assets32
Other undisclosed noncurrent assets1899712111214147
Total noncurrent assets:60,14959,49614,3548,4494,0354,105
TOTAL ASSETS:67,75767,03516,61013,6328,3237,317
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,1854,3122,0511,9091,6881,502
Accounts payable915912336248  
Accrued liabilities1871,276284284  
Employee-related liabilities5715751031097965
Taxes payable65 953385102
Other undisclosed accounts payable and accrued liabilities2,4471,5501,2331,2361,5241,335
Debt2,7893,0681,512850  
Estimated litigation liability   1672118
Other liabilities909363144263120144
Other undisclosed current liabilities   (16)(72)(118)
Total current liabilities:7,8827,7433,7063,0221,8081,646
Noncurrent Liabilities
Long-term debt and lease obligation, including:16,75219,90070  1,100
Long-term debt, excluding current maturities5212,09770  1,100
Capital lease obligations342347    
Other undisclosed long-term debt and lease obligation16,3597,455    
Liabilities, other than long-term debt6,94610,4443,0052,1601,276845
Deferred revenue and credits   71011
Accounts payable and accrued liabilities   206  
Accrued income taxes11659
Deferred tax liabilities, net4,7488,3232,2061,211561521
Other liabilities2,1982,122799737589242
Self insurance reserve    112
Other undisclosed noncurrent liabilities   (213)(127)(83)
Total noncurrent liabilities:23,69930,3443,0751,9471,1491,862
Total liabilities:31,58138,0876,7814,9692,9573,508
Stockholders' equity
Stockholders' equity attributable to parent36,17628,9489,8298,6635,3663,809
Common stock828159595956
Treasury stock, value(283)(302)(321)(346)(451)(310)
Additional paid in capital25,08224,7414,4864,3384,1862,982
Accumulated other comprehensive income (loss)1,375(1,498)(184)(32)11087
Retained earnings9,9215,9255,7884,6441,462996
Total stockholders' equity:36,17628,9489,8298,6635,3663,809
TOTAL LIABILITIES AND EQUITY:67,75767,03516,61013,6328,3237,317

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues15,16111,3976,4176,0224,9344,681
Revenue, net15,16111,3976,4176,0224,9344,681
Cost of revenue
(Cost of Goods and Services Sold)
(4,701)(1,118)(969)(979)(671)(645)
Gross profit:10,46010,2795,4485,0434,2644,036
Operating expenses(12,705)(10,434)(4,997)(4,324)(3,201)(3,732)
Other undisclosed operating income4,7011,118969979671645
Operating income:2,4559631,4201,6981,734949
Nonoperating income (expense)(562)(477)425(40)(38)
Foreign currency transaction gain (loss), before tax   16(9)(4)
Other nonoperating income (expense)7(26)49(4)(3)
Interest and debt expense(579)(470)(42)(31)(38)(38)
Other undisclosed income from continuing operations before equity method investments, income taxes57947041,6453838
Income from continuing operations before equity method investments, income taxes:1,8934861,3863,3361,694911
Income (loss) from equity method investments3(9)(2)341
Income from continuing operations before income taxes:1,8964771,3843,3391,698912
Income tax expense (benefit)2,358126(46)(56)(278)(167)
Income from continuing operations:4,2546041,3383,2831,420745
Income (loss) from discontinued operations18(276)(34)123(755) 
Net income available to common stockholders, basic:4,2723271,3033,406665745
Interest on convertible debt    2831
Net income available to common stockholders, diluted:4,2723271,3033,406693777

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:4,2723271,3033,406665745
Other comprehensive income (loss)2,873(1,314)(152)(142)23 
Comprehensive income (loss):7,144(986)1,1513,264688745
Other undisclosed comprehensive income, net of tax, attributable to parent     27
Comprehensive income (loss), net of tax, attributable to parent:7,144(986)1,1513,264688772

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: